Active, not recruitingPhase 2NCT05852171
Baricitinib in Idiopathic Granulomatous Mastitis
Studying Granulomatous mastitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- First Affiliated Hospital of Zhejiang University
- Principal Investigator
- Haiyan Wei, DoctorZhejiang University
- Intervention
- Baricitinib(drug)
- Enrollment
- 20 enrolled
- Eligibility
- 18-70 years · FEMALE
- Timeline
- 2023 – 2025
Study locations (1)
- The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05852171 on ClinicalTrials.govOther trials for Granulomatous mastitis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06712524Effect of Different Surgical Approaches of Granulomatous MastitisHubei Cancer Hospital
- RECRUITINGNCT06665399Observation Alone for Mild Non-Lactational MastitisSun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- ACTIVE NOT RECRUITINGNCT06667609Validity and Reliability of the Mastitis Symptom Severity Assessment Methods (M-Score and BISSI) in Non-Lactational MastitisSun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- RECRUITINGNCT06565845Analysis of Various Treatment Methods of Granulomatous Lobular MastitisFirst Affiliated Hospital of Harbin Medical University